Human Immunodeficiency Virus Type 1 (HIV-1) PhenoSense GT Plus Integrase
Ordering Recommendation
Intended for use in patients with viral loads ≥500 copies/mL. HIV-1 combined pheno- and genotyping test to provide antiretroviral susceptibility information for protease inhibitors (PI), reverse transcriptase inhibitors (ie, NRTI and NNRTI), and integrase inhibitors (INI). Preferred test for patients with known or suspected complex drug resistance patterns (eg, suboptimal virologic response to treatment and viral load rebound).
Methodology
Polymerase Chain Reaction/Culture
Performed
Varies
Reported
19-26 days
New York DOH Approval Status
Specimen Required
Lavender (EDTA) or plasma preparation tube (PPT).
Separate from cells within 6 hours of collection. Transfer 5 mL plasma to ARUP Standard Transport Tubes and freeze immediately. (Min: 3 mL)
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Thawed specimens.
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks
Reference Interval
By report
Interpretive Data
Performed by non-ARUP Laboratory
Note
Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
Hotline History
Hotline History
CPT Codes
87900; 87901; 87903; 87904 x16; 87906
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3001187 | EER HIV-1 PhenoSense GT + Integrase | 51969-4 |
3001188 | HIV-1 PSGT + Integrase, Net Assessment | 83326-9 |
3001189 | HIV-1 PSGT + Integrase, Phenotype | 49665-3 |
3001190 | HIV-1 PSGT + Integrase, Genotype | |
3001191 | HIV-1 PSGT + Integrase, Interpretation | 77202-0 |
Aliases
Monogram Biosciences